G2B BioSolutions Denmark ApS — Credit Rating and Financial Key Figures

CVR number: 43237748
Hagens Alle 7, 2900 Hellerup

Income statement (kDKK)

2023
2024
Fiscal period length1212
Net sales
Gross profit-5.00-9.31
EBIT-5.00-9.31
Other financial expenses-5.10-0.25
Pre-tax profit-10.10-9.56
Net earnings-10.10-9.56

Assets (kDKK)

2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current amounts owed by group member comp.40.00
Short term receivables total40.00
Cash and bank deposits34.9020.34
Cash and cash equivalents34.9020.34
Balance sheet total (assets)40.0034.9020.34

Equity and liabilities (kDKK)

2022
2023
2024
Share capital40.0040.0040.00
Retained earnings-10.10
Profit of the financial year-10.10-9.56
Shareholders equity total40.0029.9020.34
Non-current liabilities total
Short-term deferred tax liabilities5.00
Current liabilities total5.00
Balance sheet total (liabilities)40.0034.9020.34
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.